Analyst Price Target is $4.00
▲ +102.02% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Medicine Man Technologies in the last 3 months. The average price target is $4.00, with a high forecast of $4.00 and a low forecast of $4.00. The average price target represents a 102.02% upside from the last price of $1.98.
Current Consensus is
The current consensus among 1 investment analysts is to buy stock in Medicine Man Technologies.
Medicine Man Technologies, Inc. engages in the provision of advisory and consulting services related to cannabis cultivation. It operates through the following segments: Products; Licensing and Consulting; And Corporate, Infrastructure, and Other. The Products segment sells merchandise directly to customers via e-commerce portals, through the proprietary websites and retail location. The Licensing and Consulting segment refers to the licensing and consulting agreements with cannabis related entities. The Corporate, Infrastructure, and Other segment relates to the new resources added in anticipation of various acquisition transactions and other corporate related costs. The company was founded by Andrew Williams on March 20, 2014 and is headquartered in Denver, CO.